Affinity Asset Advisors’s Cyclacel Pharmaceuticals CYCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-111
| Closed | -$1.22M | – | 47 |
|
|
2022
Q1 | $1.22M | Hold |
111
| – | – | 0.2% | 35 |
|
|
2021
Q4 | $1.55M | Hold |
111
| – | – | 0.56% | 37 |
|
|
2021
Q3 | $2.11M | Buy |
111
+5
| +5% | +$95K | 0.53% | 33 |
|
|
2021
Q2 | $2.25M | Hold |
106
| – | – | 0.81% | 25 |
|
|
2021
Q1 | $2.7M | Buy |
106
+73
| +221% | +$1.86M | 0.92% | 23 |
|
|
2020
Q4 | $918K | Buy |
+33
| New | +$918K | 0.49% | 36 |
|